This HTML5 document contains 48 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
schemahttp://schema.org/
skoshttp://www.w3.org/2004/02/skos/core#
rdfshttp://www.w3.org/2000/01/rdf-schema#
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n5http://dx.doi.org/10.3109/
n10http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q78220660
rdf:type
wikibase:Item
schema:description
scientific article published on 01 January 1999 artikull shkencor i botuar më 01 janar 1999 im Jahr 1999 veröffentlichter wissenschaftlicher Artikel наукова стаття, опублікована в січні 1999 wetenschappelijk artikel artículu científicu espublizáu en xineru de 1999
p:P577
wds:Q78220660-CBB609BA-ABA1-4D9A-8447-F11C63B86DF4
wdt:P577
1999-01-01T00:00:00Z
p:P2093
wds:Q78220660-8EE7ACAE-67A9-4920-8A9A-722F090DB1B4 wds:Q78220660-634F9449-63D7-4FFF-B969-EDB93E244054 wds:Q78220660-D95D127F-8A45-4A36-917E-7DE36976FF95 wds:Q78220660-B9B6033A-B32F-4F23-AD66-4900EE29F810
wdt:P2093
K Kuromaki H Seki K Kinoshita K Satoh
rdfs:label
Trial of prophylactic administration of TXA2 synthetase inhibitor, ozagrel hydrochloride, for preeclampsia Trial of prophylactic administration of TXA2 synthetase inhibitor, ozagrel hydrochloride, for preeclampsia Trial of prophylactic administration of TXA2 synthetase inhibitor, ozagrel hydrochloride, for preeclampsia
skos:prefLabel
Trial of prophylactic administration of TXA2 synthetase inhibitor, ozagrel hydrochloride, for preeclampsia Trial of prophylactic administration of TXA2 synthetase inhibitor, ozagrel hydrochloride, for preeclampsia Trial of prophylactic administration of TXA2 synthetase inhibitor, ozagrel hydrochloride, for preeclampsia
schema:name
Trial of prophylactic administration of TXA2 synthetase inhibitor, ozagrel hydrochloride, for preeclampsia Trial of prophylactic administration of TXA2 synthetase inhibitor, ozagrel hydrochloride, for preeclampsia Trial of prophylactic administration of TXA2 synthetase inhibitor, ozagrel hydrochloride, for preeclampsia
p:P50
wds:Q78220660-EDF37A01-AE97-40BD-8A5A-7B1D453DE9FF
wdt:P50
wd:Q64215198
p:P1476
wds:Q78220660-ED6ABC13-ADDA-4B5A-963D-6EC8A2DBC74F
wdt:P1476
Trial of prophylactic administration of TXA2 synthetase inhibitor, ozagrel hydrochloride, for preeclampsia
p:P304
wds:Q78220660-1CC2D0FB-8EC1-41A7-B220-3393AC9B5405
wdt:P304
157-164
p:P31
wds:Q78220660-A250EE09-5DCE-4CF8-AC04-9CC9ABDDB1D8
wdt:P31
wd:Q13442814
p:P921
wds:Q78220660-C9E5C16C-E33C-433E-A4CD-D1AB85948A30
wdt:P921
wd:Q61335
p:P698
wds:Q78220660-58D716B0-FEF6-4C7B-A926-9AC4C072D0A1
wdtn:P698
n10:10476617
wdt:P698
10476617
p:P1433
wds:Q78220660-019406C7-18CB-452E-BB14-6C23C6997844
wdt:P1433
wd:Q5958696
p:P433
wds:Q78220660-C5B21B30-FAE0-4838-BC64-8FF79C9AE2FF
p:P478
wds:Q78220660-13F9E435-D841-4CCA-83FF-9D2DB0EF0FC4
wdt:P433
2
wdt:P478
18
p:P356
wds:Q78220660-B26613AA-3465-4FCA-A814-B18B56CE5ECC
wdtn:P356
n5:10641959909023075
wdt:P356
10.3109/10641959909023075